Skip to content
Pill with imprint G441 G441, green & yellow, capsule, 16 mm (Dantrolene Sodium 25 mg)

G441 G441 pill

Pill with imprint G441 G441 is green & yellow, capsule, 16 mm and has been identified as Dantrolene Sodium 25 mg. It is used for multiple sclerosis and muscle stiffness (spasticity). It is supplied by Amneal Pharmaceuticals of New York LLC.

Dantrolene Sodium 25 mg

Imprint
G441 G441
Strength
25 mg
Used for
Multiple sclerosis and muscle stiffness (spasticity)
Color
Green, Yellow
Shape
Capsule / oblong
Size
16 mm
Score
No score line
Form
Capsule
Manufacturer
Amneal Pharmaceuticals of New York LLC
Drug class
Muscle relaxant
NDC
0115-4411, 0115-4411-01, 0115-4411-02, 0115-4411-03, 0904-7211, 0904-7211-04

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked . Photo: Amneal Pharmaceuticals.

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dantrolene Sodium pills and guides

What is Dantrolene Sodium used for?

Dantrolene Sodium is used for multiple sclerosis and muscle stiffness (spasticity).

Medicine type
Muscle relaxant
Official uses from the US prescribing label

In Chronic Spasticity:

Dantrolene sodiumis indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). It is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. Dantrolene sodiumis not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.

If improvement occurs, it will ordinarily occur within the dosage titration (see DOSAGE AND ADMINISTRATION ), and will be manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrolene sodium.

Occasionally, subtle but meaningful improvement in spasticity may occur with dantrolene sodiumtherapy. In such instances, information regarding improvement should be solicited from the patient and those who are in constant daily contact and attendance with him. Brief withdrawal of dantrolene sodiumfor a period of 2 to 4 days will frequently demonstrate exacerbation of the manifestations of spasticity and may serve to confirm a clinical impression.

A decision to continue the administration of dantrolene sodiumon a long-term basis is justified if introduction of the drug into the patient's regimen:

produces a significant reduction in painful and/or disabling spasticity such as clonus, or

permits a significant reduction in the intensity and/or degree of nursing care required, or

rids the patient of any annoying manifestation of spasticity considered important by the patient himself.

In Malignant Hyperthermia:

Oral dantrolene sodiumis also indicated preoperatively to prevent or attenuate the development of signs of malignant hyperthermia in known, or strongly suspect, malignant hyperthermia susceptible patients who require anesthesia and/or surgery. Currently accepted clinical practices in the management of such patients must still be adhered to (careful monitoring for early signs of malignant hyperthermia, minimizing exposure to triggering mechanisms and prompt use of intravenous Dantrolene Sodium and indicated supportive measures should signs of malignant hyperthermia appear); see also the package insert for Dantrium ®(dantrolene sodium) Intravenous.

Oral dantrolene sodiumshould be administered following a malignant hyperthermic crisis to prevent recurrence of the signs of malignant hyperthermia.

From the FDA-approved label on DailyMed (published Sep 23, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows G441 G441. The parts can be split between the two sides, so turn the pill over and check both.
  • It is green & yellow, capsule, 16 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dantrolene Sodium

Inactive: Croscarmellose Sodium, Gelatin, Lactose Monohydrate, Magnesium Stearate, Starch, Corn, Titanium Dioxide, Ferric Oxide Yellow, D&c Yellow No. 10, Fd&c Green No. 3

Also distributed by

Major Pharmaceuticals

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dantrolene Sodium pills